[肿瘤学中的分子诊断与治疗] - Suppr

Suppr

超能文献

[Molecular diagnosis and therapy in oncology].

作者信息

Baretton Gustavo, Grabbe Stephan, Keilholz Ulrich, Sauter Guido

机构信息

Institut für Pathologie, Universitätsklinikum Carl Gustav Carus, TU Dresden, Germany.

出版信息

Onkologie. 2011;34 Suppl 2:5-9. doi: 10.1159/000324828.

DOI:10.1159/000324828

PMID:21447986

Abstract

摘要

相似文献

[Molecular diagnosis and therapy in oncology].

Onkologie. 2011;34 Suppl 2:5-9. doi: 10.1159/000324828.

[The pathologist and targeted therapies in oncology].

Ann Pathol. 2009 Nov;29 Spec No 1:S69-70. doi: 10.1016/j.annpat.2009.07.035.

Personalized medicine for cancer: from molecular signature to therapeutic choice.

Adv Cancer Res. 2007;96:345-69. doi: 10.1016/S0065-230X(06)96013-8.

Companion diagnostics.

Clin Adv Hematol Oncol. 2010 Jul;8(7):478-9.

[Molecular markers having a prognostic or therapeutic value in cancer].

Ann Pathol. 2008 Nov;28 Spec No 1(1):S69-70. doi: 10.1016/j.annpat.2008.09.021. Epub 2008 Oct 15.

[Target molecules of molecular target therapy of cancer].

Nihon Rinsho. 2004 Jul;62(7):1206-8.

[Molecular genetic tumor markers and their analysis for diagnosis and therapy of cancer patients].

Klin Med (Mosk). 1999;77(11):4-9.

Targeted cancer therapeutics: the heartbreak of success.

Nat Med. 2006 Aug;12(8):881-2. doi: 10.1038/nm0806-881.

Cancer biomarkers, companion diagnostics and personalized oncology.

Biomark Med. 2011 Jun;5(3):277-9. doi: 10.2217/bmm.11.29.

Telomerase as a diagnostic and therapeutic target for cancer.

Expert Rev Anticancer Ther. 2002 Apr;2(2):217-25. doi: 10.1586/14737140.2.2.217.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Molecular diagnosis and therapy in oncology].

Onkologie. 2011;34 Suppl 2:5-9. doi: 10.1159/000324828.

[The pathologist and targeted therapies in oncology].

Ann Pathol. 2009 Nov;29 Spec No 1:S69-70. doi: 10.1016/j.annpat.2009.07.035.

Personalized medicine for cancer: from molecular signature to therapeutic choice.

Adv Cancer Res. 2007;96:345-69. doi: 10.1016/S0065-230X(06)96013-8.

Companion diagnostics.

Clin Adv Hematol Oncol. 2010 Jul;8(7):478-9.

[Molecular markers having a prognostic or therapeutic value in cancer].

Ann Pathol. 2008 Nov;28 Spec No 1(1):S69-70. doi: 10.1016/j.annpat.2008.09.021. Epub 2008 Oct 15.

[Target molecules of molecular target therapy of cancer].

Nihon Rinsho. 2004 Jul;62(7):1206-8.

[Molecular genetic tumor markers and their analysis for diagnosis and therapy of cancer patients].

Klin Med (Mosk). 1999;77(11):4-9.

Targeted cancer therapeutics: the heartbreak of success.

Nat Med. 2006 Aug;12(8):881-2. doi: 10.1038/nm0806-881.

Cancer biomarkers, companion diagnostics and personalized oncology.

Biomark Med. 2011 Jun;5(3):277-9. doi: 10.2217/bmm.11.29.

Telomerase as a diagnostic and therapeutic target for cancer.

Expert Rev Anticancer Ther. 2002 Apr;2(2):217-25. doi: 10.1586/14737140.2.2.217.